Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Long-Term Deferred Tax: 2013

  • Ocular Therapeutix's Long-Term Deferred Tax was N/A to $25.8 million in Q4 2013 from the same period last year, while for Dec 2013 it was $25.8 million, marking a year-over-year change of. This contributed to the annual value of $25.8 million for FY2013, which is N/A change from last year.
  • Ocular Therapeutix's Long-Term Deferred Tax amounted to $25.8 million in Q4 2013.
  • Over the past 5 years, Ocular Therapeutix's Long-Term Deferred Tax peaked at $25.8 million during Q4 2013, and registered a low of $25.8 million during Q4 2013.
  • In the last 1 years, Ocular Therapeutix's Long-Term Deferred Tax had a median value of $25.8 million in 2013 and averaged $25.8 million.